
Sino Biopharmaceutical
Asia, Hong Kong Island, Hong Kong, Wan Chai'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
Description
Sino Biopharmaceutical is a pharmaceutical company that engages in research, development and pharmaceutical products for treating diseases.
Investor Profile
Sino Biopharmaceutical has backed more than 5 startups, with 2 new investments in the last 12 months alone. The firm has led 4 rounds, about 80% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series D, Series B, Series C rounds (top funding stages).
- Majority of deals are located in China, United States.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
- Led 2 rounds in the past year.
Stage Focus
- Series D (40%)
- Series B (20%)
- Series C (20%)
- Post Ipo Equity (20%)
Country Focus
- China (60%)
- United States (40%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Medical
- Artificial Intelligence (Ai)
- Biopharma
- Oncology
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Sino Biopharmaceutical frequently co-invest with?
Which angels does Sino Biopharmaceutical often collaborate with?
What are some of recent deals done by Sino Biopharmaceutical?
Find More Investors Like Sino Biopharmaceutical
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides









